Obesity and cancer risk in women

Archives of Gynecology and Obstetrics

Volumn 261, Issue 1, 1997, Pages 21-24

  Schindler, A E ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTRADIOL; ESTROGEN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; INSULIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADIPOSE TISSUE; ANDROGEN BLOOD LEVEL; BREAST CANCER; CANCER RISK; COLON CANCER; ENDOMETRIUM CANCER; ESTROGEN BLOOD LEVEL; FEMALE; GLUCOSE TOLERANCE; HORMONE SYNTHESIS; HUMAN; INSULIN BLOOD LEVEL; OBESITY; SHORT SURVEY; TISSUE DISTRIBUTION;

EID: 0031449830     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004040050192     Document Type: Short Survey

References (31)

1. Azzis R (1989) Reproductive endocrinologic alterations in female asymptomatic obesity. Fert Steril 52:703-725
2. Bastarrachea J, Hortobagyi GN, Smith TL, Kau SH-WC, Buzdar AU (1994) Obesity at an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Int Med 120:18-25
3. Brinton LA, Hoover L, Fraumeni JF (1983) Epidemiology of minimal breast cancer. JAMA 249:483-487
4. Bruning PF (1987) Endogenous estrogens in breast-cancer. A possible relationship between body fat distribution and estrogen availability. J Steroid Biochem 27:487-492
5. Bulun SE, Price ThM, Aitken J, Mahendroo MS, Simpson ER (1993) A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab 77:1622-1628
6. Casey ML, MacDonald BC (1983) Origin of estrogen and regulation of its formation in post- menopausal women. In: Buchsaum HJ (Hrsg) The menopause. Clinical perspectives in Obstet and Gynecol. Springer, Berlin vol 1, 1-8
7. Daniel HW (1988) Increased lymphnote metastases at mastectomie for breast cancer associated with host obesity, cigarette smoking, age and tumor size. Cancer 62:429-435
8. De Waard F (1986) Ernährung und Krebs in der Gynäkologie. In: Prävention in Gynäkologie und Geburtshilfe. Schindler AE (Hrsg) Terramed Überlingen, pp 101-111
9. De Waard F, Ramlau R, Mulders Y, de Fries T, van Waveren S (1993) A feasibility study on weight production in obese postmenopausal breast cancer patients. Eur J Cancer Prevention 2:233-238
10. Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH (1983) Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol 57:304-310
11. Ewertz M, Schou G, Boice JD (1988) The joint effect of risk factors on endometrial cancer. Eur J Cancer Clin Oncol 21: 189-194
12. Kirschner MA, Schneider G, Ertel NH, Worton E (1982) Obesity, androgens, Estrogens, and cancer risk. Cancer Research [Suppl] 42: 3281-3285
13. Le Marchand L, Wilkens LR, Mi MP (1992) Obesity in yougth and middle age and risk of colorectal cancer in men. Cancer causes and Control 3:349-354
14. Levi F, Vecchia CL, Negri E, Parazzini F, Franchesschi S (1992) Body mass at different ages and subsequent endometrial cancer risk. Int J Cancer 50:567-571
15. Loucks AB, Heat EM, Law T, Verdun M, Watts JR (1994) Dietary restriction reduces luteinizing hormone (LH) pulse frequency during waking hours and increases LH pulse amplitude during sleep in young menstruating women. J Clin Endocrinol Metab 78:910-915
16. Lupulescu A (1993) Estrogen use and cancer risk: a review. Exp Clin Endocrinol 110:204-214
17. Maggino T, Marcadella CB, Romagnolo C (1993) The role of insulin and renin in the pathogenesis of hormone-dependent neoplasias a) Insulin. Eur J Gyneaecol Oncol XIV, 131-134
18. Miller AB, Berrino F, Hill M, Pietinen P, Riboli E, Wahrendorf J (1994) Diet in the etiology of cancer: a review. Eur J Canc 30A:207-220
19. Møller H, Mellemgaard A, Lindvig K, Olsen JH (1994) Obesity and cancer risk: a danish record-linkage study. Eur J Canc 30A:344-350
20. Nyholm HCJ, Nielsen AL, Lyndrup J, Dreisler A, Hagen C, Hang E (1993) Plasma oestrogen in postmenopausal women with endometrial cancer. J Obstet Gynecol 100: 1115-1119
21. Pathak DR, Whittemore AS (1992) Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries. Am J Epidemiol 135:153-168
22. Research Reports NIHD, July 1994
23. Roe FJ, Lee PN, Conybeare G, Kelly D, Prenctice D, Matter B (1991) Risk of premature death and cancer predicted by body weight in early adult life. Hum Exp Toxicol 10: 285-288
24. Rutanen EM, Stenman S, Blum W, Kärkkäinen T, Lehtovirta P, Stenman UH (1993) Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls. J Clin Endocrinol Metab 77:199-294
25. Samojlik E, Kirschner MA, Silber D, Schneider G, Ertel NH (1984) Elevated production and metabolic clearance rates of androgens in morbidly obese women. J Clin Endocrinol Metab 58:949-954
26. Schapiro DV, Clark RA, Wolff PA, Jarrett AR, Kumar NB, Azis NM (1994) Visceral obesity and breast cancer risk. Cancer 7:632-639
27. Schindler AE (1994) Obesity health hazard for women. Current Obstet Gynecol 4: 37-40
28. Stewart AJ, Johnson MD, May FEB, Westly BR (1990) Role of insulin-like growth factors and the type I Insulin-like growth factor receptor int the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 265:21172-21178
29. Stoll BA, Vatten LJ, Kvinnsland St (1994) Does early physical maturity influence breast cancer risk? Acta Endocrinol 33:171-176
30. von Holst Th, Eggert-Kruse W, Klinga K, Runnebaum B (1989) Die Bedeutung von Übergewicht für die Bioverfügbarkeit der Östrogene bei Frauen in der Prä- und Postmenopause. Act Endocrin Stoffw 10:13-16
31. Zumoff B (1982) Relationship of obesity to blood estrogens. Cancer Res [Suppl 42] 3289-3293